mometasone-furoate has been researched along with Neoplasm-Metastasis* in 1 studies
1 other study(ies) available for mometasone-furoate and Neoplasm-Metastasis
Article | Year |
---|---|
Severe Psoriasis Flare After Anti-Programmed Death Ligand 1 (PD-L1) Therapy for Metastatic Non-Small Cell Lung Cancer (NSCLC).
Immunomodulatory agents that target PD-1 and its ligand (PD-L1) are being increasingly used in the management of lung cancer. Potential immune-related adverse events include dermatological complications which mostly are of low grade severity. The use of immune checkpoint inhibitors may lead to the exacerbation of autoimmune conditions. We report a case of a documented psoriasis flare with anti-PD-1 treatment for lung cancer. Topics: Adenocarcinoma; Aged; Antibodies, Monoclonal; Antineoplastic Agents; B7-H1 Antigen; Calcitriol; Carcinoma, Non-Small-Cell Lung; Cigarette Smoking; Disease Progression; ErbB Receptors; Exons; Humans; Male; Mometasone Furoate; Neoplasm Metastasis; Phototherapy; Psoriasis; Sequence Deletion | 2016 |